アジア太平洋地域のバイオ製造におけるウイルス検出および定量化市場：分析・予測 (2023-2032年)

アジア太平洋地域のバイオ製造におけるウイルス検出および定量化市場：イントロダクション

アジア太平洋地域のバイオ製造におけるウイルス検出および定量化の市場規模は、2023年の1億1,000万米ドルから、予測期間中は10.47%のCAGRで推移し、2032年には2億8,000万米ドルの規模に成長すると予測されています。

同市場の成長は、バイオ医薬品の使用の増加と業界でのウイルス検査技の術進歩によって推進されると予測されています。

アジア太平洋地域のバイオ製造におけるウイルス検出および定量化市場は現在、急速なペースで進展しています。この成長は、同地域でのバイオ医薬品の採用の増加に起因しています。バイオ医薬品の安全性、有効性、一貫性を確保するための強固な品質管理プロセスに対する厳しいニーズが、生物製剤製造におけるウイルス汚染物質の定量化に使用される消耗品や機器に対する需要を促進しています。アジア太平洋地域でバイオ医薬品業界の進歩が受け入れられるにつれ、ウイルス検出および定量化ソリューションの需要が急増する見通しです。

当レポートでは、アジア太平洋地域のバイオ製造におけるウイルス検出および定量化の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、主要国別の詳細分析、主要企業の分析などをまとめています。

市場の分類

セグメンテーション1：提供タイプ別

• 消耗品
• 機器
• サービス

セグメンテーション2：技術別

• PCR法
• ELISA法
• フローサイトメトリー
• プラークアッセイ
• その他

セグメンテーション3：用途別

• 血液および血液製剤製造
• ワクチンおよび治療薬製造
• 細胞・遺伝子治療製品製造
• 幹細胞製品製造
• 組織および組織製品製造

セグメンテーション4：エンドユーザー別

• ライフサイエンス企業
• 試験機関
• CROおよびCDMO

セグメンテーション5：国別

• 中国
• 日本
• 韓国
• オーストラリア
• インド
• その他

目次

エグゼクティブサマリー

第1章 市場の範囲

第2章 調査手法

第3章 市場概要

• 概要
• 現在の市場規模と将来の成長可能性

第4章 業界の展望

• 規制状況

第5章 バイオ製造におけるウイルス検出および定量化市場：市場力学

• 事業促進要因
  • バイオ医薬品利用の拡大
  • ウイルス検出および定量化における技術の進歩
  • 影響分析
• 事業上の制約
  • 高度なウイルス検出および定量化装置の高コスト性
  • ウイルス検出および定量化の分野で訓練を受けた専門家の不足
  • 影響分析
• 事業機会
  • 細胞治療および遺伝子治療の開発におけるウイルス汚染への配慮の必要性の増大

第6章 バイオ製造におけるウイルス検出および定量化市場：地域別

• 概要
• アジア太平洋
  • 提供タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別

第7章 市場：競合ベンチマーキング・企業プロファイル

• 概要
• 企業シェア分析
• エコシステムで活発な企業
• TAKARA HOLDINGS INC.

List of Figures

• Figure 1: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
• Figure 2: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
• Figure 3: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
• Figure 4: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
• Figure 5: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
• Figure 6: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Research Methodology
• Figure 7: Primary Research Methodology
• Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 9: Top-Down Approach (Segment-Wise Analysis)
• Figure 10: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
• Figure 11: Biomanufacturing Viral Detection and Quantification Market (by Region)
• Figure 12: Measures Undertaken by APAC to Enhance its Viral Testing Capacity
• Figure 13: Asia-Pacific: Market Dynamics
• Figure 14: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
• Figure 15: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 16: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 17: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 18: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 19: China Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 20: China Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 21: China Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 22: China Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 23: China Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 24: Japan Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 25: Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 26: Japan Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 27: Japan Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 28: Japan Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 29: India Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 30: India Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 31: India Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 32: India Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 33: India Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 34: Australia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 35: Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 36: Australia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 37: Australia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 38: Australia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 39: South Korea Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 40: South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 41: South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 42: South Korea Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 43: South Korea Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 44: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 45: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 46: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 47: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 48: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 49: Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
• Figure 50: Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
• Figure 51: TAKARA HOLDINGS INC.: Product Portfolio
• Figure 52: TAKARA HOLDINGS INC.: Overall Financials, $Million, 2020-2022
• Figure 53: TAKARA HOLDINGS INC.: Revenue (by Region), $Million, 2020-2022
• Figure 54: TAKARA HOLDINGS INC.: R&D Expenditure, $Million, 2020-2022

List of Tables

• Table 1: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
• Table 2: Key Questions Answered in the Report
• Table 3: Methods of Virus Detection and Quantification
• Table 4: Biomanufacturing Viral Detection and Quantification Market: Regulatory Scenario
• Table 5: Technological Advancement in the Field of Viral Testing
• Table 6: Impact Analysis: Business Drivers
• Table 7: Impact Analysis: Business Restraints

“The Asia-Pacific Biomanufacturing Viral Detection and Quantification Market Expected to Reach $0.28 Billion by 2032.”

Introduction to Asia-Pacific Biomanufacturing Viral Detection and Quantification Market

The Asia-Pacific biomanufacturing viral detection and quantification market was valued at $0.11 billion in 2023 and is anticipated to reach $0.28 billion by 2032, witnessing a CAGR of 10.47% during the forecast period 2023-2032. The biomanufacturing viral detection and quantification market growth is anticipated to be propelled by the increasing use of biopharmaceutical products and the technological advancements in viral testing within the industry.

Market Introduction

The Asia-Pacific (APAC) biomanufacturing viral detection and quantification market is currently advancing at a rapid pace. This growth can be attributed to the increasing adoption of biopharmaceuticals within the region. The stringent need for robust quality control processes to ensure the safety, efficacy, and consistency of biopharmaceutical products is driving the demand for consumables and instruments used in quantifying viral contaminants during the biomanufacturing of biologics. As APAC embraces the biopharmaceutical industry's advancements, the demand for viral detection and quantification solutions is expected to surge. This presents a significant opportunity for manufacturers and providers of biomanufacturing viral detection and quantification products in the APAC market, as they play a pivotal role in ensuring the integrity and safety of biopharmaceutical production processes in the region.

Market Segmentation:

Segmentation 1: by Offering Type

• Consumables
• Instruments
• Services

Segmentation 2: by Technology

• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others

Segmentation 3: by Application

• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

• Life Science Companies
• Testing Laboratories
• CROs and CDMOs

Segmentation 5: by Country

• China
• Japan
• South Korea
• Australia
• India
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the APAC biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Market Scope

• 1.1. Key Questions Answered in the Report

2. Research Methodology

3. Market Overview

• 3.1. Overview
• 3.2. Current Market Size and Future Growth Potential, $Billion, 2022-2032

4. Industry Outlook

• 4.1. Regulatory Landscape
  • 4.1.1. Legal Requirements and Frameworks in Asia-Pacific
    • 4.1.1.1. Legal Requirements and Framework in Japan

5. Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

• 5.1. Business Drivers
  • 5.1.1. Increasing Utilization of Biopharmaceuticals
  • 5.1.2. Technological Advancements in Viral Detection and Quantification
  • 5.1.3. Impact Analysis
• 5.2. Business Restraints
  • 5.2.1. High Cost of Advanced Viral Detection and Quantification Equipment
  • 5.2.2. Lack of Trained Professionals in the Field of Viral Detection and Quantification
  • 5.2.3. Impact Analysis
• 5.3. Business Opportunities
  • 5.3.1. Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

6. Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

• 6.1. Overview
• 6.2. Asia-Pacific
  • 6.2.1. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • 6.2.2. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • 6.2.3. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
  • 6.2.4. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 6.2.5. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
    • 6.2.5.1. China
      • 6.2.5.1.1. China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.1.2. China Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.1.3. China Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.1.4. China Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.2. Japan
      • 6.2.5.2.1. Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.2.2. Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.2.3. Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.2.4. Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.3. India
      • 6.2.5.3.1. India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.3.2. India Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.3.3. India Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.3.4. India Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.4. Australia
      • 6.2.5.4.1. Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.4.2. Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.4.3. Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.4.4. Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.5. South Korea
      • 6.2.5.5.1. South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.5.2. South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.5.3. South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.5.4. South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.6. Rest-of-Asia-Pacific
      • 6.2.5.6.1. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.6.2. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.6.3. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.6.4. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)

7. Markets - Competitive Benchmarking & Company Profiles

• 7.1. Overview
• 7.2. Company Share Analysis
• 7.3. Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
• 7.4. TAKARA HOLDINGS INC.
  • 7.4.1. Company Overview
  • 7.4.2. Role of TAKARA HOLDINGS INC. in the Biomanufacturing Viral Detection and Quantification Market
  • 7.4.3. Key Competitors
  • 7.4.4. Financials
  • 7.4.5. Key Insights about the Financial Health of the Company
  • 7.4.6. Analyst Perspective